Vanta Bioscience

Vanta_Bioscience03 May 2024

Miscellaneous

₹

+3.54 (+4.94%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Vanta Bioscience

Vanta Bioscience

Miscellaneous

Vanta_Bioscience03 May 2024

₹

+3.54 (+4.94%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
01-Apr-2024	BC	Appointment of CS and Compliance Officer w.e.f 01.04.2024	01-Apr-2024
01-Apr-2024	BC	Appointment of CS and Compliance Officer w.e.f 01.04.2024	01-Apr-2024
08-Nov-2023	BC	Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the un-audited financial results of the Co	14-Nov-2023
14-Nov-2023	BC	Outcome of Board Meeting held on 14.11.2023 Change in Designation of Dr. Vyasmurti Madhavrao Shingatgeri from WTD to Non Executive Director w.e.f 14.11.2023	14-Nov-2023
06-Sep-2023	BC	AGM on 30.09.2023 Voting Results and Scrutinizers Report for 7th AGM of the Company held on 30.09.2023 (As Per BSE Announcement Dated on 04/10/2023)	30-Sep-2023

No Rights has been declared by Vanta_Bioscience

Book Closure

Record Date	Split Date	Purpose
01-Apr-2024	-	Appointment of CS and Compliance Officer w.e.f 01.04.2024
01-Apr-2024	-	Appointment of CS and Compliance Officer w.e.f 01.04.2024
14-Nov-2023	-	Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the un-audited financial results of the Co
14-Nov-2023	-	Outcome of Board Meeting held on 14.11.2023 Change in Designation of Dr. Vyasmurti Madhavrao Shingatgeri from WTD to Non Executive Director w.e.f 14.11.2023
30-Sep-2023	-	AGM on 30.09.2023 Voting Results and Scrutinizers Report for 7th AGM of the Company held on 30.09.2023 (As Per BSE Announcement Dated on 04/10/2023)

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Vanta Bioscience Ltd ₹75.20(+3.54/4.94%)	75.20	+3.54	47.47	43.92	0.00	2.40
MPIL Corporation Ltd ₹805.95(-42.40/-5.00%)	805.95	-42.40	45.94	207.03	69.60	2.98
Jaykay Enterprises Ltd ₹129.45(-4.00/-3.00%)	129.45	-4.00	756.73	155.28	128.17	5.28
Modi Rubber Ltd ₹100.00(+2.35/2.41%)	100.00	+2.35	250.40	65.18	11.35	0.66
FGP Ltd ₹7.40(+0.34/4.82%)	7.40	+0.34	8.81	24.37	0.00	2.76
TCI Industries Ltd ₹1,408.50(+56.15/4.15%)	1,408.50	+56.15	126.77	10.91	0.00	13.73

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	6.31	6.31	6.31	6.31	6.31	5.73
Reserves Total	13.43	17.68	17.60	17.13	15.93	10.86
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	19.74	23.99	23.91	23.44	22.24	16.59
Secured Loans	18.24	17.29	16.68	13.55	13.25	11.18
Unsecured Loans	7.52	3.48	0.60	0.60	0.00	0.00
Total Debt	25.76	20.77	17.28	14.15	13.25	11.18
Total Liabilities	45.50	44.76	41.19	37.59	35.49	27.77
APPLICATION OF FUNDS :
Gross Block	43.69	41.16	33.11	23.23	19.18	18.06
Less : Accumulated Depreciation	6.29	5.04	3.72	2.47	1.28	0.57
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	37.40	36.12	29.39	20.76	17.90	17.49
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	3.70	2.34
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.00	3.00	3.00	3.00	3.95	4.50
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	7.16	7.24	9.76	14.01	9.24	3.02
Sundry Debtors	1.92	0.72	1.98	1.36	1.56	0.33
Cash and Bank	0.07	0.07	0.07	0.09	0.28	0.09
Loans and Advances	1.98	2.98	1.70	2.03	1.01	1.04
Total Current Assets	11.13	11.00	13.51	17.48	12.10	4.48
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	5.33	4.86	4.28	3.35	1.99	1.14
Provisions	0.00	0.00	0.06	0.06	0.12	0.03
Total Current Liabilities	5.33	4.86	4.34	3.41	2.11	1.17
Net Current Assets	5.80	6.14	9.17	14.07	9.99	3.31
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.81	0.78	0.72	0.59	0.40	0.23
Net Deferred Tax	-0.81	-0.78	-0.72	-0.59	-0.40	-0.23
Total Assets	45.39	44.48	40.84	37.24	35.14	27.41
Contingent Liabilities	0.00	0.00	1.01	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.07	0.07	0.09	0.28	0.09
Net Cash from Operating Activities	0.64	6.70	11.01	3.17	-0.06
Net Cash Used In Investing Activities	-2.53	-8.08	-9.96	-1.56	-4.70
Net Cash Used In Financing Activities	1.88	1.38	-1.07	-1.80	4.96
Net Inc./Dec In Cash And Cash Equivalents	0.00	0.00	-0.02	-0.20	0.20
Cash And Cash Equivalents At End Of The Year	0.07	0.07	0.07	0.09	0.28

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

69.36%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

30.64%

**Promoter pledged shareholding 69.36%

About Vanta Bioscience Ltd

Vanta Bioscience Ltd is in the Miscellaneous sector, having a market capitalization of Rs. 47.47 crores. It has reported a sales of Rs. 3.47 crores and a net profit of Rs. -2.73 crores for the quarter ended December 2018. The company management includes Mohan Krishna Mulakala, Mohan Krishna Mulakala,Dopesh Raja Mulakala,Vyasmurti Madhavrao Shingatgeri,Padmanabhuni Venkata Appaji,Zoheb Sayani,Sadhanala Venkata Rao,Yogeswara Rao Danda (Vanta Bioscience Ltd) among others.

Chairman

Mohan Krishna Mulakala

Registered office

No.02/G/308/G Umajay Complex,Rasoolpura Secunderabad,Hyderabad,Telangana,500003

FAX :91-40-27908708

Background

Incorporation Year2016

Face Value₹10

Market Lot1500

How to buy Vanta Bioscience shares on nse?

To buy Vanta Bioscience shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Vanta Bioscience share price today?

The Vanta Bioscience shares price on nse is Rs.75.2 today.

What is the market cap of Vanta Bioscience shares on BSE ?

The company has a market capitalization of Rs.47.47Cr

What is the PE & PB ratio of Vanta Bioscience shares ?

PE is 0 and PB is 2.4

What is the 52 Week High and Low of Vanta Bioscience shares?

Vanta Bioscience stock price high: Rs.101.64 Vanta Bioscience stock price low: Rs.37